Addendum: Commentary on becaplermin gel (Regranex) for hemangiomas.
Frieden
Ilona J
IJ
Division of Pediatric Dermatology, UCSF Children's Hospital, University of California, San Francisco School of Medicine, San Francisco, CA, USA.
D000077214:Becaplermin; D005782:Gels; D006391:Hemangioma / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D015994:Incidence; D009369:Neoplasms / Q000150:complications / Q000453:epidemiology / Q000401:mortality; D010982:Platelet-Derived Growth Factor / Q000008:administration & dosage* / Q000009:adverse effects*; D020574:Proto-Oncogene Proteins c-sis; D014456:Ulcer / Q000188:drug therapy / Q000209:etiology; D014481:United States; D014486:United States Food and Drug Administration
D005782:Gels; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D000077214:Becaplermin